Finoriq research workspace
Autonomix Medical, Inc. (AMIX) Historical Metrics
Autonomix Medical, Inc. develops technology for patients with pancreatic cancer and addresses. Review AMIX valuation ratios, fundamentals, and filing metrics on Finoriq.
Company Snapshot
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
- Company
- Autonomix Medical, Inc. (AMIX)
- Ticker
- AMIX
- Market Cap
- $2.4M
- Latest Price
- $4.36
- Industry
- Medical Devices
Autonomix Medical, Inc. (AMIX) Current Valuation Metrics
Static valuation preview for Autonomix Medical, Inc. (AMIX). Market data retrieved 2026-07-09. Filing currency USD.
| Metric | Value | Source |
|---|---|---|
| Earnings YieldLatest TTM net income divided by market cap. | -476.2% | Net Income | TTM FY 2026 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | -349.9% | Operating Cash Flow | TTM FY 2026 |
| Price / BookMarket cap divided by stockholders' equity. | 0.6x | Stockholders' Equity | FY 2026 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.